Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL9452572 | 1.00 | ALDH1A1 (0.80) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL7738712 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL22284066 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL231054 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| Biphenyl SCHEMBL2997707 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL241806 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL7741464 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL22284064 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL2999797 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL48866 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486934-A | Preparation method of chemiluminescent agent and chemiluminescent agent | 苏州亚科科技股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-10411301-B2 | Ionic liquids and preparation method thereof | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2019-09-10 | — | — | US | claimed |
| CN-109020979-A | A kind of electroluminescent organic material and preparation method and application with heterocycle structure | 中节能万润股份有限公司 | 2018-12-18 | — | — | CN | claimed |
| US-20170222266-A1 | IONIC LIQUIDS AND PREPARATION METHOD THEREOF | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2017-08-03 | — | — | US | claimed |
| US-9365596-B2 | Method for preparing quaternary phosphonium salts | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2016-06-14 | — | — | US | claimed |
| US-20150166587-A1 | METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS | MICROVAST POWER SYSTEMS CO., LTD. (CN) | 2015-06-18 | — | — | US | claimed |
| EP-1070075-B1 | CHIRAL PHOSPHORATED LIGANDS USEFUL IN CATALYSTS | CHEMI SPA (IT) | 2003-10-08 | — | — | EP | claimed |
| EP-1070075-A1 | CHIRAL PHOSPHORATED LIGANDS USEFUL IN CATALYSTS | CHEMI S.p.A. (IT) | 2001-01-24 | — | — | EP | claimed |
| WO-1999052915-A1 | CHIRAL PHOSPHORATED LIGANDS USEFUL IN CATALYSTS | CHEMI S.P.A. (IT) | 1999-10-21 | — | — | WO | claimed |
| EP-0333489-B1 | Process for the removal of heavy metal ions from phosphoric acid | IMI TAMI INSTITUTE RESEARCH (IL) | 1994-06-22 | — | — | EP | claimed |
| EP-4701782-A1 | CATALYST SYSTEM AND ETHYLENE OLIGOMERIZATION PROCESS FOR THE PREPARATION OF LINEAR ALPHA OLEFINS | Chevron Phillips Chemical Company LP (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4701783-A1 | PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES | Chevron Phillips Chemical Company LP (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-3609891-B1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA CELLULAR THERAPIES INC (US) | 2026-02-11 | — | — | EP | disclosed |
| CN-117355373-B | Ethylene oligomerization process | 切弗朗菲利浦化学公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119528662-A | Preparation method of trans-S-alkenyl thio pyridazine compound | 常州大学 | 2025-02-28 | — | — | CN | disclosed |
| US-4081491-A | HEAT CURABLE | SHELL OIL COMPANY (US) | 1978-03-28 | — | — | US | disclosed |
| US-4061681-A | Method for the preparation of mono- or poly [dialkyl or dicycloalkylphosphonylmethyl] aromatic carbocyclic compounds | AMERICAN CYANAMID COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
| US-3988152-A | Epoxy resin photoresist with iodoform and bismuth triphenyl | AMERICAN CAN COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
| US-3977874-A | CATIONIC CATALYST, PHOTOPOLYMERIZATION | AMERICAN CAN COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
| US-3977878-A | Epoxy resin photoresist with iodoform and bismuth triphenyl | AMERICAN CAN COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222266-A1 | IONIC LIQUIDS AND PREPARATION METHOD THEREOF | DNMT3A, SOD1, CLK2 | ALDH1A1 3407/4885HSD17B10 4199/4885SLC18A3 882/4885 |
| US-10411301-B2 | Ionic liquids and preparation method thereof | DNMT3A, SOD1, CLK2 | ALDH1A1 3407/4885HSD17B10 4199/4885SLC18A3 882/4885 |
| US-20150166587-A1 | METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS | PHPT1, PHOSPHO1, PTEN | ALDH1A1 4827/4885HSD17B10 2780/4885SLC18A3 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.